Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
The American Heart Hospital Journal|September 11, 2009
Contrast-induced nephropathy-choice of contrast agents to reduce renal riskRichard E KatholiInternational Journal of Hypertension|July 15, 2011
Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applicationsRichard E Katholi, Daniel M CouriInternational Journal of Hypertension|December 27, 2013
Renal denervation for treating resistant hypertension: current evidence and future insights from a global perspectiveY Castro Torres, Richard E KatholiWorld Journal of Diabetes|August 16, 2014
Novel treatment approaches in hypertensive type 2 diabetic patientsYaniel Castro Torres, Richard E KatholiCurrent Cardiology Reviews|May 1, 2020
Recently Approved and Under Investigation Drugs for Treating Patients with Heart FailureYaniel Castro-Torres, Richard E KatholiProgress in Cardiovascular Diseases|November 18, 2009
The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention on their clinical significance?Richard E Katholi, Krishna J Rocha-SinghWorld Journal of Clinical Cases|August 25, 2015
Ventricular repolarization markers for predicting malignant arrhythmias in clinical practiceYaniel Castro-Torres, Raimundo Carmona-Puerta, Richard E KatholiClinical Cardiology|May 3, 2006
Use and side-effect profile of spironolactone in a private cardiologist's practiceEric M Williams, Richard E Katholi, Marcey R KarambelasRevista Da Associacao Medica Brasileira (1992)|April 25, 2015
Natriuretic peptides, obesity and cardiovascular diseasesYaniel Castro-Torres, Yaniel Castro Torres, Richard E KatholiJournal of Diabetes and Its Complications|April 17, 2008
Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiographyKathy J Hardiek, Richard E Katholi, Randall S Robbs, et al.Pageof 2